Neurohealing Pharmaceuticals Inc.

The premature ejaculation treatment market is projected to grow by USD 1.46 billion from 2024-2028, driven by high efficacy of off-label drugs and nanotechnology advancements. Key players include A. Menarini, Absorption Pharmaceuticals, Alembic Pharmaceuticals, and others. Challenges include side effects and pandemic-related access issues, with AI and telemedicine offering potential solutions.